AMAG Pharmaceuticals, Inc. to Present at the 28th Annual J.P. Morgan Healthcare Conference

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that Brian J.G. Pereira, MD, President and CEO, will present an overview of the Company and provide an update on the commercial launch of Feraheme® (ferumoxytol) Injection at the 28th Annual J.P. Morgan Healthcare Conference on January 11, 2010 at 11:00 a.m. P.T.

MORE ON THIS TOPIC